We are live on
!
Find out more
SC
Slow Capital Portfolio holdings
AUM
$857M
1-Year Est. Return
38.3%
This Fund
S&P 500
This Quarter
Est. Return
+13.89%
1 Year Est. Return
+38.3%
3 Year Est. Return
+123.69%
5 Year Est. Return
+154.77%
10 Year Est. Return
–
AUM
$251M
AUM Growth
+$43.7M
(+21%)
Cap. Flow
+$16.3M
Cap. Flow
% of AUM
6.47%
Top 10 Holdings %
Top 10 Hldgs %
21.51%
Holding
163
New
22
Increased
65
Reduced
71
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
KZR
Kezar Life Sciences
KZR
|
+$3.87M |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.9M |
| 3 |
iShares MBS ETF
MBB
|
+$1.88M |
| 4 |
Qiagen
QGEN
|
+$1.84M |
| 5 |
iShares National Muni Bond ETF
MUB
|
+$1.55M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$1.68M |
| 2 |
iShares Preferred and Income Securities ETF
PFF
|
+$1.16M |
| 3 |
Amazon
AMZN
|
+$1.11M |
| 4 |
Meta Platforms (Facebook)
META
|
+$524K |
| 5 |
iShares Global Consumer Discretionary ETF
RXI
|
+$523K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.37% |
| 2 | Technology | 19.56% |
| 3 | Consumer Discretionary | 11.56% |
| 4 | Healthcare | 10.87% |
| 5 | Financials | 7.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
State Street Health Care Select Sector SPDR ETF
XLV
$44.5B
| $333K | 0.13% |
3,629
| – | – |
|
152
Acuity Brands
AYI
$10B
| $327K | 0.13% |
2,728
+23
| +0.9% | +$2.86K |
|
153
SolarEdge
SEDG
$1.93B
| $318K | 0.13% |
8,443
+539
| +7% | +$21.5K |
|
|
EPZM
154
DELISTED
Epizyme, Inc
EPZM
| $317K | 0.13% |
+25,559
| New | +$286K |
|
155
WisdomTree US Multifactor Fund
USMF
$284M
| $307K | 0.12% |
+10,589
| New | +$299K |
|
156
iShares Global Energy ETF
IXC
$2.79B
| $277K | 0.11% |
8,222
-2,259
| -22% | -$73.9K |
|
157
McDonald's
MCD
$188B
| $265K | 0.11% |
+1,394
| New | +$253K |
|
158
iShares S&P 500 Growth ETF
IVW
$76.8B
| $261K | 0.1% |
+6,060
| New | +$248K |
|
159
Procter & Gamble
PG
$334B
| $232K | 0.09% |
+2,231
| New | +$217K |
|
160
Biogen
BIIB
$32.3B
| $208K | 0.08% |
881
-738
| -46% | -$232K |
|
161
Editas Medicine
EDIT
$485M
| – | – |
-14,307
| Closed | -$325K |
|
162
Intellia Therapeutics
NTLA
$1.8B
| – | – |
-21,166
| Closed | -$289K |
|
|
163
Qualcomm
QCOM
$175B
| – | – |
-29,551
| Closed | -$1.68M |
|
Similar funds
MCM
AAM
PFA
AIMC
QIM
SFO
UW
PWG
Slow Capital's Q1 2019 Portfolio in Review
As of Q1 2019, Slow Capital held 163 positions worth $251M, up 21% from $208M the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Slow Capital deployed $16.3M of net new capital in Q1 2019, opening 22 new positions and adding to 65 existing holdings. Its largest new stake was iShares 20+ Year Treasury Bond ETF: 15,591 shares worth $1.97M.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 27% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was iShares Preferred and Income Securities ETF, an estimated $1.16M trimmed.
- Slow Capital's largest Q1 2019 buy was iShares 20+ Year Treasury Bond ETF: 15,591 shares worth $1.97M.
- Slow Capital added most to Kezar Life Sciences in Q1 2019, an estimated $3.87M increase.
- Slow Capital's biggest Q1 2019 reduction was iShares Preferred and Income Securities ETF, cutting an estimated $1.16M.
- Slow Capital fully exited Qualcomm in Q1 2019, selling an estimated $1.68M.
- Slow Capital's ten largest holdings make up 22% of its $251M portfolio in Q1 2019.
- Slow Capital opened 22 new positions and closed 3 in Q1 2019.
- Slow Capital's portfolio value rose 21% quarter-over-quarter to $251M.
Based on Slow Capital's 13F filing for Q1 2019, filed 16 May 2019.